**
In a shocking case that raises serious concerns about patient safety and medical ethics, Dr. Mohsen Ali has been removed from the medical register after allegedly defrauding vulnerable cancer patients. Operating from an unlicensed clinic within his council house, Dr. Ali charged exorbitant fees—up to £15,000—for questionable treatments involving garlic oil injections, claiming a 90 per cent cure rate. The tribunal’s ruling not only exposes the inadequacies of oversight in alternative medicine but also highlights the urgent need for stringent regulatory measures to protect patients.
Unsanitary Practices and Misleading Claims
Dr. Ali, who held a medical licence from 2004 until its withdrawal in January 2015, operated a clinic that was described as “squalid” and “unsanitary.” His premises included a decaying mattress in the garden and non-sterilised containers found in a Halfords box. Such conditions raise alarming questions about the safety of the treatments he provided. During consultations, he assured one patient, suffering from stage three prostate cancer, that their illness was “so easy to cure” that he would offer a refund if he failed. This unfounded confidence in his methods suggests a serious breach of professional ethics.
Between January and September 2018, Dr. Ali treated two cancer patients, both of whom sought his services after being told by medical professionals that conventional treatment options were their best chance for recovery. Misleadingly presenting himself as a qualified doctor with extensive experience, he advertised a miraculous cure for cancer, claiming an impressive success rate that had no basis in scientific evidence.
Exploitation of Trust
The tribunal’s findings revealed a pattern of manipulation and exploitation of vulnerable individuals. In one instance, a patient, known only as Patient A, was convinced by Dr. Ali that NHS doctors were merely profit-driven and that his treatment would offer a more effective solution. Dr. Ali’s refusal to disclose the ingredients of his injections, which he claimed included Vitamin C and garlic oil, further emphasises the lack of transparency and informed consent that is crucial in medical practice.
Dr. Ali’s second patient, referred to as Patient B, had ovarian cancer and was informed by Dr. Ali that he could provide a cure despite her terminal diagnosis. Following her treatment, which included a cocktail of dubious substances, she passed away shortly thereafter. The husband of Patient B later expressed his dismay, stating that payments were made under false pretences, highlighting the profound emotional and financial toll on families affected by cancer.
Regulatory Failures and Future Implications
The investigation into Dr. Ali’s practices began after a complaint was lodged with the General Medical Council in June 2019, leading to a police report a month later. Despite acknowledging his lack of registration, Dr. Ali defended his actions by claiming that his work was merely therapeutic and involved natural remedies. Such a stance reflects a profound misunderstanding of medical ethics and responsibility.
The Medical Practitioners Tribunal Service ultimately concluded that Dr. Ali posed a “high and ongoing risk” to public safety. Nessa Sharkett, chair of the tribunal, stated that his actions constituted “misleading” behaviour that exploited vulnerable patients. The tribunal’s decision to strike him off underscores the necessity for rigorous oversight in the medical field, particularly concerning unregulated alternative treatments.
Why it Matters
This case serves as a stark reminder of the vulnerabilities faced by patients seeking treatment for debilitating illnesses like cancer. It underscores the urgent need for better regulation of alternative medicine practices and highlights the importance of accountability in the healthcare system. Patients, often in desperate situations, must be protected from exploitative practices that prey on their fear and hope. The ramifications of such unethical behaviour extend beyond individual cases; they can erode trust in medical professionals and systems, making it essential for regulatory bodies to act decisively to safeguard public health.
